Dalbavancin | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Dalbavancin
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Quotient Sciences- Molecule to Cure. Fast.

Contact Supplier

pharmacompass-2-m-2025-08-25

Dalbavancin

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

25 API Suppliers, 7 USDMF, 4 NDC API, 17 Listed Suppliers, $ API Reference Price

25 API Suppliers
7 USDMF
4 NDC API
17 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

INTERMEDIATES

1 Intermediate Suppliers

1 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

3 FDF Dossiers, 1 FDA Orange Book, 2 Europe

3 FDF Dossiers
1 FDA Orange Book
2 Europe

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 13 SPI Pharma, 3 Gangwal Healthcare, 1 Nanjing Well Pharmaceutical, 1 Pfanstiehl, 1 BASF, 2 DFE Pharma, 2 Gangwal Chemicals, 1 Ingredion Pharma Solutions, 10 Kerry, 4 Microlex e.U, 2 Pluviaendo, 3 Roquette, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 2 Sigachi Industries

1 Rochem International Inc
13 SPI Pharma
3 Gangwal Healthcare
1 Nanjing Well Pharmaceutical
1 Pfanstiehl
1 BASF
2 DFE Pharma
2 Gangwal Chemicals
1 Ingredion Pharma Solutions
10 Kerry
4 Microlex e.U
2 Pluviaendo
3 Roquette
1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd
1 Shijiazhuang Huaxu Pharmaceutical
2 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

26 Fillers, Diluents & Binders, 15 Direct Compression, 12 Chewable & Orodispersible Aids, 10 Granulation, 10 Taste Masking, 7 Disintegrants & Superdisintegrants, 5 Co-Processed Excipients, 5 Parenteral, 1 Solubilizers, 1 Thickeners and Stabilizers

26 Fillers, Diluents & Binders
15 Direct Compression
12 Chewable & Orodispersible Aids
10 Granulation
10 Taste Masking
7 Disintegrants & Superdisintegrants
5 Co-Processed Excipients
5 Parenteral
1 Solubilizers
1 Thickeners and Stabilizers

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 1 Regulatory FDF Prices, 4 Annual Reports

1 US Medicaid Prescriptions
1 Regulatory FDF Prices
4 Annual Reports

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

1 US Patents, 2 Health Canada Patents

1 US Patents
2 Health Canada Patents

REF. STANDARDS & IMPURITIES

1 Others

1 Others

$ API Ref.Price (USD/KG) : 128,762 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

2 All

01 1Paladin Labs Inc.

02 1Paladin Pharma Inc.

filter Patent Reset all filters

2 All

01 12506236

02 12564112

filter Product Reset all filters

2 All

01 2DALBAVANCIN HYDROCHLORIDE

filter Dosage Reset all filters

2 All

01 2POWDER FOR SOLUTION

filter Exp Date Reset all filters

2 All

01 12023-11-14

02 12025-04-26

Product Main Page

01

Paladin Labs Inc.

DALBAVANCIN HYDROCHLORIDE

Coatings Trends

Not Confirmed

Paladin Labs Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2023-11-14

Date Granted : 2018-07-17

DALBAVANCIN HYDROCHLORIDE

Brand Name : XYDALBA

Patent Number : 2506236

Filing Date : 2003-11-14

Strength per Unit : 500 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2023-11-14

Date Granted : 2018-07-17

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

02

Paladin Pharma Inc.

DALBAVANCIN HYDROCHLORIDE

Coatings Trends

Not Confirmed

Paladin Pharma Inc.

Country

Coatings Trends

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-04-26

Date Granted : 2014-08-05

DALBAVANCIN HYDROCHLORIDE

Brand Name : XYDALBA

Patent Number : 2564112

Filing Date : 2005-04-26

Strength per Unit : 500 mg / vial

Dosage Form : POWDER FOR SOLUTION

Human Or VET : Human

Route of Administration : INTRAVENOUS

Patent Expiration Date : 2025-04-26

Date Granted : 2014-08-05

Portfolio PDF

Product Web Link

Virtual Booth

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!